Insider · CIK 0002132552
Liane Rae Teplitsky
Files at PLSE (Pulse Biosciences, Inc.). First filing Aug 28, 2026, latest Sep 2, 2026.
In brief
Liane Rae Teplitsky files SEC Form 4 as COO at PLSE (Pulse Biosciences, Inc.). Since Aug 28, 2026, Liane Rae Teplitsky has reported 2 open-market buys worth $200k and 0 open-market sells worth $0, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Liane Rae Teplitsky has 0, so none is measured yet.
The newest scored trade: bought $100k of PLSE on Aug 31, 2026, filed Sep 2, 2026, scored 45 (moderate). In the last 12 months: 2 buys worth $200k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PLSE: Pulse Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | PLSEbuy Pulse Biosciences, Inc. | $100k 2,025 shares | +98% | +298% from low-0% from high | |
| 38Weak | PLSEbuy Pulse Biosciences, Inc. | $100k 2,070 shares | - | +280% from low-5% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +1,024 | $48.80 | $50k | 3,094 | 42 d ago |
| Sep 1, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +1,001 | $49.95 | $50k | 4,095 | 42 d ago |
| Aug 26, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +1,036 | $48.24 | $50k | 1,036 | Aug 28, 2026 |
| Aug 8, 2026 | PLSE Pulse Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +200,000 | $0.00 | $0 | 200,000 | Aug 28, 2026 |
| Aug 28, 2026 | PLSE Pulse Biosciences, Inc. | POpen-market purchase Common Stock | +1,034 | $48.35 | $50k | 2,070 | Aug 28, 2026 |
| Aug 8, 2026 | PLSE Pulse Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +700,000 | $0.00 | $0 | 700,000 | Aug 28, 2026 |
Questions about Liane Rae Teplitsky
Answered from the filings on this page, as of the latest one.
Is Liane Rae Teplitsky buying or selling?
In the last 12 months Liane Rae Teplitsky reported 2 open-market buys worth $200k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of PLSE on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Liane Rae Teplitsky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Liane Rae Teplitsky has 0.
Where does Liane Rae Teplitsky file Form 4?
Liane Rae Teplitsky has filed Form 4 at PLSE (Pulse Biosciences, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.